PRO Consortium Measures and Licensing
The PRO Consortium establishes and maintains a collaborative framework for the qualification of patient-reported outcome measures and other clinical outcome assessment tools.
The mission of the PRO Consortium is to establish and maintain a collaborative framework with appropriate stakeholders for the qualification of patient-reported outcome (PRO) measures and other clinical outcome assessment (COA) tools that will be publicly available for use in clinical trials where COA-based endpoints are used to support product labeling claims.
On this site, you will find information regarding available measures covering different therapeutic areas. Details about each measure, including target populations, measurement descriptions, translations and licensing requirements, can be accessed through our measures page.